Tickerplace logo

Tickerplace

Aquestive Therapeutics, Inc. logo

AQSTAquestive Therapeutics, Inc.

AQST Stock Price, Valuation & Chart | Aquestive Therapeutics, Inc.

Compare
$3.780-0.28 (-6.90%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
OverviewFinancialsDividendsRatios

AQST Historical price chart

AQST Key Stats

Market Capitalization474.43M
PE Ratio-5.82
EPS-0.65
Trading Volume5.23M
Today's High/Low4.08/3.75
Dividend Yield0.00
52 Week High/Low7.55/2.93
Shares Outstanding125.51M
AQST Financial Statement
AQST Analyst ratings
AQST Analysis & performance metrics

AQST Company profile

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United…

AQST Management team

Management
Lori J. Braender BSBA, Esq., J.D.
Chief Legal Officer, Chief Compliance Officer & Secretary
Sherry Korczynski
Senior Vice President of Sales & Marketing
Daniel BarberCEO
Chief Executive Officer, President & Director
A. Ernest Toth Jr.CFO
Chief Financial Officer
Cassie JungCOO
Chief Operating Officer
Carl N. Kraus M.D.
Chief Medical Officer
Melina T. Cioffi
Senior Vice President of Regulatory Affairs
Peter E. Boyd
Senior Vice President of Information Technology & Human Resources
Total 8 executives

AQST Frequently asked questions

What is Aquestive Therapeutics, Inc. (AQST) Stock Price?

Current stock price of Aquestive Therapeutics, Inc. (AQST) stock is $3.780. The stock price is -6.90% lower in the session. The intraday range can be seen from this page. Volume of Aquestive Therapeutics, Inc. (AQST) stock is 5.23M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Aquestive Therapeutics, Inc. (AQST) stock price going up or down today?

The stock price of Aquestive Therapeutics, Inc. (AQST) can change with earnings, company news, and overall market sentiment. Aquestive Therapeutics, Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Aquestive Therapeutics, Inc. stock expensive at its current price?

Whether Aquestive Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for AQST on this page is -5.82. EPS on this page is -0.65. Compare those figures with peers and growth expectations before deciding if the current Aquestive Therapeutics, Inc. price is justified.

How has the stock price of Aquestive Therapeutics, Inc. (AQST) performed historically?

Historical performance for Aquestive Therapeutics, Inc. (AQST) is shown on the price chart on this page. Review multi-period moves alongside volume to see how AQST reacted to past earnings and market events.

Should I buy Aquestive Therapeutics, Inc. (AQST) stock, at this price?

Buying Aquestive Therapeutics, Inc. (AQST) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.